Table IV.
Single virus samples | n | Ct rangea |
---|---|---|
FLA | 10 | 23.6–34.6 |
FLB | 17* | 18.8–32.5 |
HRV | 4 | 23.5–36.0 |
ADV | 10 | 20.4–32.4 |
MPNV | 7 | 20.6–31.5 |
RSV | 9 | 23.4–36.4 |
PF1 | 9 | 22.7–30.6 |
PF2 | 5* | 20.7–32.7 |
PF3 | 7 | 23.3–32.6 |
Dual virus samples | n |
---|---|
ADV and PF3 | 1 |
FLB and HRV | 1 |
FLB and PF3 | 1 |
FLA and PF2 | 1 |
RSV and ADV | 2* |
Either single targets (left‐hand two columns of the top part) or two targets (two columns of the bottom part) were detected in each sample by in‐house multiplex RT‐PCR.
Four FLB, two PF2, and both RSV‐ADV dually infected samples had been tested previously in the RV12 evaluation. All viruses in these repeated samples had been previously detected by the RV12 system. In addition to the 12 targets detected by RV12, RV15 also detects human bocavirus, human parainfluenza 4, and enterovirus.
Ct ranges are derived from both single and dual virus samples.